Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gavish

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
International Journal of Obesity (2005)|February 25, 2009
Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis?M Shargorodsky, M Boaz, Y Goldberg, et al.
Journal of Clinical Pharmacology|June 1, 1995
The effect of lovastatin on early restenosisY Beigel, N Zafrir, Y Teplitzky, et al.
Atherosclerosis|January 22, 2008
Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patientsM Mashavi, R Hanah, M Boaz, et al.
Bone|June 3, 2008
Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factorsA Luckish, R Cernes, M Boaz, et al.
Circulation|November 1, 1989
HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levelsG M Kostner, D Gavish, B Leopold, et al.
Archives of Internal Medicine|April 1, 1987
Bulimia. An underlying behavioral disorder in hyperlipidemic pancreatitis: a prospective multidisciplinary approachD Gavish, S Eisenberg, E M Berry, et al.
Blood Pressure|November 5, 2003
Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program--initial cost utility analysisC Yosefy, G M Ginsberg, D Dicker, et al.
Preventive Medicine|November 26, 2003
The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortalityC Yosefy, D Dicker, J R Viskoper, et al.
European Heart Journal|March 31, 2000
Medical history of hypercholesterolaemia adversely affects the outcome of out-of-hospital cardiopulmonary resuscitation; the 'Shahal' experience in IsraelA Roth, M Golovner, D Gavish, et al.
Journal of the American College of Cardiology|June 7, 2000
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsD S Silverberg, D Wexler, M Blum, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
International Journal of Obesity (2005)|February 25, 2009
Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis?M Shargorodsky, M Boaz, Y Goldberg, et al.
Journal of Clinical Pharmacology|June 1, 1995
The effect of lovastatin on early restenosisY Beigel, N Zafrir, Y Teplitzky, et al.
Atherosclerosis|January 22, 2008
Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patientsM Mashavi, R Hanah, M Boaz, et al.
Bone|June 3, 2008
Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factorsA Luckish, R Cernes, M Boaz, et al.
Circulation|November 1, 1989
HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levelsG M Kostner, D Gavish, B Leopold, et al.
Archives of Internal Medicine|April 1, 1987
Bulimia. An underlying behavioral disorder in hyperlipidemic pancreatitis: a prospective multidisciplinary approachD Gavish, S Eisenberg, E M Berry, et al.
Blood Pressure|November 5, 2003
Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program--initial cost utility analysisC Yosefy, G M Ginsberg, D Dicker, et al.
Preventive Medicine|November 26, 2003
The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortalityC Yosefy, D Dicker, J R Viskoper, et al.
European Heart Journal|March 31, 2000
Medical history of hypercholesterolaemia adversely affects the outcome of out-of-hospital cardiopulmonary resuscitation; the 'Shahal' experience in IsraelA Roth, M Golovner, D Gavish, et al.
Journal of the American College of Cardiology|June 7, 2000
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsD S Silverberg, D Wexler, M Blum, et al.
Pageof 5